The Peptide Report
SLU-PP-332 sits in a unique regulatory category in 2026 — not FDA-approved, not a controlled substance, but classified for research use. Here's what buyers need to know before purchasing.
SLU-PP-332 sits in a unique regulatory category in 2026 — not an approved drug, not a dietary supplement, but a research compound with specific legal nuances. Here's what consumers need to understand before purchasing.
